Browse by Section 100 Item List

HIGHLY SPECIALISED DRUGS PROGRAM (Public Hospital)

For Highly Specialised Drugs prescribed through public hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Maximum quantities and repeats for Highly Specialised Drugs are listed in the Schedule. Highly Specialised Drugs prescribed through public hospitals, except Complex Authority Required Highly Specialised Drugs, are Authority required (STREAMLINED) PBS Prescriptions. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats. Complex Authority Required Highly Specialised Drugs require written authority applications. Approval of authority prescriptions by Services Australia may be obtained either by posting an Authority Prescription Form to Services Australia, or by using the Services Australia Authority free-call service (1800 888 333). Prescribers must quote the provider number of the hospital when applying.

Public hospital prescriptions for Highly Specialised Drugs can be dispensed by public hospital pharmacies. A patient will be required to pay a contribution for each supply of a highly specialised drug at a similar rate to the Pharmaceutical Benefits Scheme. Commonwealth subsidy is not available for hospital in-patients.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 5670K PAMIDRONATE DISODIUMpamidronate disodium 90 mg/10 mL injection, 10 mL vial 1 1 11
MP 5667G PAMIDRONATE DISODIUMpamidronate disodium 15 mg/5 mL injection, 5 mL vial 4 4 2
MP 5669J PAMIDRONATE DISODIUMpamidronate disodium 60 mg/10 mL injection, 10 mL vial 1 1 2
MP 5668H PAMIDRONATE DISODIUMpamidronate disodium 30 mg/10 mL injection, 10 mL vial 2 2 2
MP 10882R PASIREOTIDEpasireotide 60 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack 2 2 5
MP 10883T PASIREOTIDEpasireotide 40 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack 2 2 5
MP 10886Y PASIREOTIDEpasireotide 20 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack 2 2 5
MP 9514R PEGFILGRASTIMpegfilgrastim 6 mg/0.6 mL injection, 0.6 mL syringe 1 1 11
MPNP 9515T PEGINTERFERON ALFA-2Apeginterferon alfa-2a 135 microgram/0.5 mL injection, 4 x 0.5 mL syringes 2 8 5
MPNP 9516W PEGINTERFERON ALFA-2Apeginterferon alfa-2a 180 microgram/0.5 mL injection, 4 x 0.5 mL syringes 2 8 5
MP 11179J PEGVISOMANTpegvisomant 10 mg injection [30 vials] (&) inert substance diluent [30 syringes], 1 pack 1 1 5
MP 11173C PEGVISOMANTpegvisomant 15 mg injection [30 vials] (&) inert substance diluent [30 syringes], 1 pack 1 1 5
MP 11181L PEGVISOMANTpegvisomant 20 mg injection [30 vials] (&) inert substance diluent [30 syringes], 1 pack 1 1 5
MP 11177G PEGVISOMANTpegvisomant 20 mg injection [1 vial] (&) inert substance diluent [1 syringe], 1 pack 4 4 0
MP 10083Q PLERIXAFORplerixafor 24 mg/1.2 mL injection, 1.2 mL vial 1 1 1
MP 10387Q POMALIDOMIDEpomalidomide 4 mg capsule, 21 1 21 0
MP 10406Q POMALIDOMIDEpomalidomide 3 mg capsule, 21 1 21 0